EDIT
Editas Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.23
+4.87%Margins
Gross margin
56.9%
EBITDA margin
-149.4%
EBIT margin
-174.7%
Net margin
-157.3%
FCF margin
-256.5%
-70.2%
Return on equity
-31.2%
Return on assets
-68.0%
Return on invested capital
0.24x
Asset turnover
-$119.9M
Cash from operations
$1.38
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026